介素-33增加了2型先天性淋巴细胞的数量,并在eosinophilic喘中增加了它们的激活
Fengfei Sun1,2, Wei Zou1,2, Honglei Shi1,2
1Department of Pulmonary and Critical Care Medicine, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Clinical and translational allergy
|June 26, 2023
概括
激活的2型先天性淋巴细胞 (ILC2s) 是酸性喘 (EA) 的关键. 介质素-33 (IL-33) 通过PI3K/AKT通路激活ILC2s,这表明EA的抗IL-33疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
- 细胞生物学 细胞生物学
背景情况:
- 介质素-33 (IL-33) 与喘恶化有关,可能是通过2型先天性淋巴细胞 (ILC2) 引起的.
- ILC2s在酸性喘 (EA) 中的特定作用以及IL-33对ILC2s作用的机制需要进一步阐明.
研究的目的:
- 调查ILC2s和EA之间的关联.
- 在EA的背景下澄清IL-33影响ILC2s的机制.
主要方法:
- 从EA患者的外周血液,唾液和支气管支气管洗液中量化和特征化ILC2.
- 在人类和小鼠模型中对IL-33刺激的反应评估了ILC2功能,包括增殖和基因表达.
- 使用共聚焦显微镜和分子分析来检查EA中的ILC2局部化和信号通路.
主要成果:
- 在EA患者中观察到较高的ILC2计数和激活,与疾病严重程度标志物相关.
- 在EA模型中,IL-33刺激促进了ILC2在肺组织中的扩散和积累.
- IL-33通过PI3K/AKT通路激活ILC2s,导致IL-5和IL-13的产生增加,反IL-33治疗可以逆转效应.
结论:
- 激活的ILC2s作为EA的重要生物标志物.
- IL-33通过PI3K/AKT通路驱动EA中的ILC2诱导和激活.
- 用抗体向IL-33是管理EA的潜在治疗策略.
相关概念视频
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Antiasthma Drugs: Leukotriene Modifiers
371
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
371
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
357
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
357
Drugs Used in Lower Respiratory Disorders: Overview
504
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
504
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.3K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K


